Psivant Therapeutics
Evan Chiswick is currently serving as the Director of Biology at Psivant Therapeutics. Prior to this role, Evan held various positions at Roivant Sciences, Silicon Therapeutics, and Massachusetts Institute of Technology, where Evan focused on research related to systems biology models and inflammatory network analysis. Evan also has experience as a Postdoctoral Research Fellow at Boston University School of Medicine and as a QC Analyst III at Oxthera, inc. Evan holds a PhD in Immunology from Boston University and a Bachelor's degree in Biology from Keene State College.
Psivant Therapeutics
Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.